(Reuters) - Drugmaker AbbVie Inc said it will buy Pharmacyclics Inc , the maker of blockbuster cancer drug Imbruvica, for about $21 billion to boost its oncology drugs pipeline.
from Reuters: Most Read Articles http://ift.tt/1DXCDdI http://www.reuters.com
from Reuters: Most Read Articles http://ift.tt/1DXCDdI http://www.reuters.com
No comments:
Post a Comment